Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - yongquan+shen
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments
Alzheimer’s disease (AD) is one of the most prominent and feared neurodegenerative diseases associated with aging. A hallmark of this disease is the formation of extra-cellular amyloid plaques in the brain. The principle component of these extracellular plaques is amyloid-ß protein (Aß). Though the mechanisms underlying Alzheimer’s...
Published: 4/19/2023
|
Inventor(s):
Michael Sierks
,
Yong Shen
Keywords(s):
Category(s):
Pharmaceuticals
,
Life Science (All LS Techs)
,
Neurodegenerative Disease Technologies
,
Non-Cancer Therapeutics
Targeting Podoplanin to Combat Cancer
Sentrimed® is launching its first product, MASL®, to treat and prevent cancer and arthritis. Our technology is protected by issued patents and proprietary technology tailored to combat cancer and inflammatory diseases by targeting a unique receptor, called podoplanin (PDPN), which is expressed by cancer and inflammatory cells. We have received...
Published: 2/16/2024
|
Inventor(s):
Gary Goldberg
,
Yongquan Shen
Keywords(s):
Cancer
,
Compounds
,
Therapeutic
Category(s):
Human Health Care > Therapeutics